Executive Team

We improve patient outcomes, creating competitive advantage.

Our Executive Team

Cycle’s Executive Team includes accomplished leaders with deep and broad industry experience alongside entrepreneurial executives, defining new and exciting growth opportunities.

James Harrison" alt="James Harrison - Group CEO">

James Harrison

Group CEO

James Harrison founded Cycle Pharmaceuticals in 2012. James was formerly CEO of Archimica, an international contract manufacturing organisation of active pharmaceutical ingredients and their pre-cursors for the global branded and generic...

James Harrison founded Cycle Pharmaceuticals in 2012. James was formerly CEO of Archimica, an international contract manufacturing organisation of active pharmaceutical ingredients and their pre-cursors for the global branded and generic pharmaceutical industries. Archimica has manufacturing sites in the US, UK, Germany, France and Italy. During his tenure at Archimica, James recruited and led a new management team, and implemented a detailed strategic repositioning of the business. Archimica was sold to the Euticals group in 2011.

Prior to Archimica, James was a Managing Director at TowerBrook Capital Partners and a Partner at Soros Private Equity Partners. James began his career working in the mergers and acquisitions department of Morgan Stanley. James is an Honorary Fellow of Robinson College, University of Cambridge, and holds MA and MPhil degrees from the University of Cambridge.

View LinkenIn profile

Read more
Steve McCue" alt="Steve McCue - Group CFO">

Steve McCue

Group CFO

Steve McCue has extensive international business and finance leadership experience gained across sectors such as specialty chemicals, electronics manufacturing and more recently high volume wholesale distribution. Prior to Cycle, Steve was Group CFO of Paris based, Euronext listed...

View LinkenIn profile

Read more
Chikai Lai" alt="Chikai Lai - SVP & CCO ">

Chikai Lai

SVP & CCO

Chikai (Kai) Lai is Cycle’s Senior Vice President and Chief Commercial Officer. Mr. Lai is in charge of Cycle’s operations in United States, managing the P&L of Cycle’s US business including Cycle’s hub services and Cycle’s products, as well as Cycle’s business relationships with industry partners...

Chikai (Kai) Lai is Cycle’s Senior Vice President and Chief Commercial Officer. Mr. Lai is in charge of Cycle’s operations in United States, managing the P&L of Cycle’s US business including Cycle’s hub services and Cycle’s products, as well as Cycle’s business relationships with industry partners.

Since joining Cycle in 2014, Mr. Lai has played an important role in delivering Cycle’s innovative products to markets. He served in various functions, including Regulatory Affairs, ROW (ex-US) Commercial and Operations and Program Management.

Prior to Cycle, Mr. Lai worked in product development at TWi Pharmaceuticals, Inc. a Taiwan-based, US-focused pharmaceutical company focused on developing Paragraph IV and 505(b)(2) products.

Mr. Lai received both a B.Pharm. and an M.S. in Pharmaceutical Sciences from Taipei Medical University in Taiwan, and an M.Phil. in Bioscience Enterprise from University of Cambridge in the United Kingdom.
Mr. Lai currently serves as a member of the Board of Trustees of the CGD Society, a global leading patient advocacy group for Chronic Granulomatous Disease, as well as the Board of Trustees of Jeans for Genes Campaign.

View LinkenIn profile

Read more
Steve Fuller" alt="Steve Fuller - SVP & CSO">

Steve Fuller

SVP & CSO

Steve Fuller is Cycle’s Senior Vice President and Chief Strategy Officer. As CSO, Steve is working to grow Cycle’s current products by reaching more patients, in addition to building Cycle’s pipeline with new development and partnership opportunities...

Steve Fuller is Cycle’s Senior Vice President and Chief Strategy Officer. As CSO, Steve is working to grow Cycle’s current products by reaching more patients, in addition to building Cycle’s pipeline with new development and partnership opportunities.

Steve joined Cycle Pharmaceuticals in 2013 following the completion of a PhD in analytical chemistry at the University of Cambridge. As Cycle’s first employee, Steve started as Business Development Manager, supporting the development of Cycle’s first rare disease products. He then transitioned to Head of Regulatory Affairs to lead drug approval processes with the FDA, Health Canada, and the EMA, building the innovative regulatory team at the heart of Cycle’s growth. More recently, as Head of Business development, Steve established Cycle’s US supply chain and specialty pharmacy operations to allow Cycle to manage its own rare disease distribution channel, and in-license rare disease products to grow Cycle’s portfolio.

View LinkenIn profile

Read more
Sarah Gowing" alt="Sarah Gowing - Group General Counsel & Company Secretary">

Sarah Gowing

Group General Counsel & Company Secretary

Sarah Gowing is the Group General Counsel and Company Secretary of Cycle Group Holdings Limited, and a director of the operating companies, Cycle Pharmaceuticals Limited and Varsity Pharmaceuticals Limited. Sarah joined Cycle in 2020, and brings a wealth of private...

View LinkenIn profile

Read more
Zac Bohlen" alt="Zac Bohlen - Vice President, US Sales">

Zac Bohlen

Vice President, US Sales

Zac Bohlen is Vice President, Head of Sales, US, overseeing and leading sales for all of Cycle’s branded products in the US. Mr Bohlen joined Cycle in January 2020 as Head of Operations. Mr Bohlen is an executive commercial leader with over 22 years of success in biotech...

View LinkenIn profile

Read more
Catherine Wainwright" alt="Catherine Wainwright - Product Development & Regulatory Affairs">

Catherine Wainwright

Product Development & Regulatory Affairs

Catherine Wainwright is the Senior Director of Product Development & Regulatory Affairs. She joined Cycle in 2014 and since this time has supported the development of NITYR® (nitisinone) tablets, Cycle’s generics portfolio and the launch of TASCENSO ODT® (fingolimod)...

View LinkenIn profile

Read more
Romina Briffa" alt="Romina Briffa - Quality">

Romina Briffa

Quality

Romina Briffa is an experienced quality assurance professional with expertise and training in pharmacy, higher education, and the pharmaceutical industry. A pharmacist by training, Dr. Briffa obtained her Master of Science specialized in industrial pharmacy and is experienced in GDP...

View LinkenIn profile

Read more
Chris Shaw" alt="Chris Shaw - Human Resources">

Chris Shaw

Human Resources

Chris Shaw is Cycle’s Head of HR with responsibility for leading the future of work strategy across the business. With over 15 years of experience in HR ranging from Fortune 500 companies to AIM listed SMEs, Mr Shaw has worked across multiple industries...

View LinkenIn profile

Read more